# MYNN

## Overview
The MYNN gene encodes the myoneurin protein, a transcriptional repressor that plays a pivotal role in regulating gene expression. Myoneurin is categorized as a member of the POK family of proteins, characterized by the presence of an amino-terminal POZ/BTB domain and multiple Kruppel-type zinc fingers, which facilitate protein-protein interactions and DNA binding, respectively (Mou2024Comprehensive). This protein is predominantly expressed in neuromuscular junctions, where it is integral to muscle attachment and neuromuscular network regulation (Mou2024Comprehensive). Myoneurin is involved in various biological processes, including telomere length regulation and developmental pathways, and interacts with several proteins, such as ubiquitin C and COP9 Signalosome Subunit 5, implicating it in key signaling pathways like the JNK and MAPK cascades (Mou2024Comprehensive). Mutations in the MYNN gene, such as the SNP rs10936599, have been linked to diseases like cancer, highlighting the clinical significance of this gene and its protein product (Mou2024Comprehensive).

## Structure
The MYNN gene encodes the myoneurin protein, which is 610 amino acids long and primarily functions as a transcriptional repressor. It is part of the POK family and features an amino-terminal POZ/BTB domain and eight Kruppel-type zinc fingers at the carboxy-terminal. The POZ/BTB domain facilitates protein-protein interactions through dimerization, leading to heterochromatin formation and transcription inhibition, while the zinc fingers are responsible for DNA binding (Mou2024Comprehensive).

The secondary structure of the myoneurin protein includes alpha helices, extended strands, and beta-turns, with slight differences observed between the wildtype and variant structures due to the non-synonymous SNP rs10936599 (Mou2024Comprehensive). Tertiary structure analysis using I-TASSER indicates significant deviation between the wildtype and variant structures, with a Root Mean Square Deviation (RMSD) of 5.968 and a TM-score of 0.84197, suggesting that the structures are roughly in the same topology (Mou2024Comprehensive).

The variant MYNN protein, resulting from the SNP rs10936599, shows a decreased radius of gyration, indicating quicker folding and a more stable hydrophobic core compared to the wildtype (Mou2024Comprehensive). The mutation is located near the BTB domain, potentially affecting the protein's interaction with other molecules (Mou2024Comprehensive).

## Function
The MYNN gene encodes the myoneurin protein, which functions primarily as a transcriptional repressor. It is involved in regulating gene expression by binding to specific DNA sequences through its Kruppel-type zinc finger motifs, which are responsible for the protein's DNA binding properties (Mou2024Comprehensive). The protein contains an amino-terminal POZ/BTB domain that facilitates protein-protein interactions with transcriptional co-factors, such as corepressors and histone deacetylases, leading to the formation of heterochromatin and inhibition of transcription activation (Mou2024Comprehensive).

Myoneurin is highly expressed in neuromuscular junctions and plays a crucial role in regulating muscle attachment and neuromuscular networks (Mou2024Comprehensive). It is involved in several biological processes, including the regulation of telomere length, gene expression, and developmental processes (Mou2024Comprehensive). The protein interacts with several other proteins, such as ubiquitin C and COP9 Signalosome Subunit 5, and is involved in numerous signaling and regulatory pathways, including the JNK cascade, MAPK cascade, and cell cycle regulation (Mou2024Comprehensive). These interactions and processes highlight the protein's significant role in transcription regulation, enzyme binding, and translation initiation (Mou2024Comprehensive).

## Clinical Significance
Mutations in the MYNN gene, particularly the single nucleotide polymorphism (SNP) rs10936599, have been associated with several diseases, including colorectal cancer, bladder cancer, and multiple myeloma (Mou2024Comprehensive). This SNP is linked to shorter telomere lengths, which is a marker of biological aging and may contribute to cancer development (Mou2024Comprehensive). The rs10936599 variant is predicted to be functionally deleterious, causing significant structural deviations in the myoneurin protein, which may affect its normal interactions and functions (Mou2024Comprehensive).

The MYNN gene's role in cancer is further highlighted by the interaction of its protein product with other proteins and ligands. Molecular docking studies have shown that the rs10936599 variant binds more effectively with the NOTCH2 protein, potentially altering signaling pathways involved in tumorigenesis (Mou2024Comprehensive). Additionally, non-coding SNPs in the MYNN gene can disrupt transcription factor binding sites and miRNA target sites, which may affect gene regulation and contribute to disease susceptibility (Mou2024Comprehensive).

Alterations in MYNN expression or mutations can disrupt cellular processes, contributing to the pathogenesis of various diseases, including certain cancers and neurological disorders (Mou2024Comprehensive).

## Interactions
The MYNN (myoneurin) protein is involved in various protein-protein interactions that influence cellular processes. It interacts with several proteins, including ubiquitin C (UBC), COP9 Signalosome Subunit 5 (COPS5), P21 (RAC1) Activated Kinase 1 (PAK1), and ELAV-like protein 1 (ELAVL1), indicating its role in diverse cellular functions (Mou2024Comprehensive). These interactions suggest that MYNN is involved in signaling and regulatory pathways such as the JNK and MAPK cascades, cell cycle regulation, and transcription (Mou2024Comprehensive).

The MYNN protein also exhibits a higher binding affinity with NOTCH2 in its variant form, as demonstrated by molecular docking studies. The mutant MYNN protein binds with a docking score of -269.55 compared to -254.7 for the wildtype, indicating a stronger interaction (Mou2024Comprehensive). This enhanced interaction may have implications for its functional role in cellular processes.

The MYNN gene's involvement in transcriptional regulation is facilitated by its amino-terminal POZ/BTB domain and Kruppel-type zinc fingers, which enable protein-protein interactions and DNA binding, respectively (Mou2024Comprehensive). These structural features support its participation in multiprotein complexes and its regulatory influence on gene expression.


## References


[1. (Mou2024Comprehensive) Sadia Islam Mou, Tamanna Sultana, Dipankor Chatterjee, Md. Omar Faruk, and Md. Ismail Hosen. Comprehensive characterization of coding and non-coding single nucleotide polymorphisms of the myoneurin (mynn) gene using molecular dynamics simulation and docking approaches. PLOS ONE, 19(1):e0296361, January 2024. URL: http://dx.doi.org/10.1371/journal.pone.0296361, doi:10.1371/journal.pone.0296361. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0296361)